Matches in SemOpenAlex for { <https://semopenalex.org/work/W2394692324> ?p ?o ?g. }
- W2394692324 endingPage "5504" @default.
- W2394692324 startingPage "5488" @default.
- W2394692324 abstract "In the present study, a series of novel histone deacetylase (HDAC) inhibitors using the morpholinopurine as the capping group were designed and synthesized. Several compounds demonstrated significant HDAC inhibitory activities and antiproliferative effects against diverse human tumor cell lines. Among them, compound 10o was identified as a potent class I and class IIb HDAC inhibitor with good pharmaceutical profile and druglike properties. Western blot analysis further confirmed that 10o more effectively increased acetylated histone H3 than panobinostat (LBH-589) and vorinostat (SAHA) at the same concentration in vitro. In in vivo efficacy evaluations of HCT116, MV4-11, Ramos, and MM1S xenograft models, 10o showed higher efficacy than SAHA or LBH-589 without causing significant loss of body weight and toxicity. All the results indicated that 10o could be a suitable candidate for treatment of both solid and hematological cancer." @default.
- W2394692324 created "2016-06-24" @default.
- W2394692324 creator A5002450016 @default.
- W2394692324 creator A5002661071 @default.
- W2394692324 creator A5013277489 @default.
- W2394692324 creator A5019291385 @default.
- W2394692324 creator A5020019896 @default.
- W2394692324 creator A5027269469 @default.
- W2394692324 creator A5031046349 @default.
- W2394692324 creator A5039360390 @default.
- W2394692324 creator A5039832836 @default.
- W2394692324 creator A5056975844 @default.
- W2394692324 creator A5057830915 @default.
- W2394692324 creator A5074149482 @default.
- W2394692324 creator A5077666079 @default.
- W2394692324 creator A5080610727 @default.
- W2394692324 creator A5082475531 @default.
- W2394692324 creator A5085462851 @default.
- W2394692324 date "2016-05-24" @default.
- W2394692324 modified "2023-10-06" @default.
- W2394692324 title "Development of Purine-Based Hydroxamic Acid Derivatives: Potent Histone Deacetylase Inhibitors with Marked in Vitro and in Vivo Antitumor Activities" @default.
- W2394692324 cites W1511815964 @default.
- W2394692324 cites W1754523296 @default.
- W2394692324 cites W1981711832 @default.
- W2394692324 cites W2001669845 @default.
- W2394692324 cites W2008756733 @default.
- W2394692324 cites W2012651834 @default.
- W2394692324 cites W2015645056 @default.
- W2394692324 cites W2018523772 @default.
- W2394692324 cites W2018872626 @default.
- W2394692324 cites W2023404623 @default.
- W2394692324 cites W2029754521 @default.
- W2394692324 cites W2047390792 @default.
- W2394692324 cites W2052815426 @default.
- W2394692324 cites W2059898454 @default.
- W2394692324 cites W2071115015 @default.
- W2394692324 cites W2071715575 @default.
- W2394692324 cites W2074678272 @default.
- W2394692324 cites W2080377507 @default.
- W2394692324 cites W2081973434 @default.
- W2394692324 cites W2087066381 @default.
- W2394692324 cites W2094362542 @default.
- W2394692324 cites W2094383719 @default.
- W2394692324 cites W2099803844 @default.
- W2394692324 cites W2101127235 @default.
- W2394692324 cites W2101663014 @default.
- W2394692324 cites W2102901106 @default.
- W2394692324 cites W2105668062 @default.
- W2394692324 cites W2106900373 @default.
- W2394692324 cites W2107661677 @default.
- W2394692324 cites W2107733280 @default.
- W2394692324 cites W2112296880 @default.
- W2394692324 cites W2112351720 @default.
- W2394692324 cites W2132880072 @default.
- W2394692324 cites W2140513457 @default.
- W2394692324 cites W2156012049 @default.
- W2394692324 cites W2169004576 @default.
- W2394692324 cites W2170925020 @default.
- W2394692324 cites W2255564941 @default.
- W2394692324 cites W2312511398 @default.
- W2394692324 cites W2319386786 @default.
- W2394692324 cites W2326463045 @default.
- W2394692324 cites W2328092060 @default.
- W2394692324 doi "https://doi.org/10.1021/acs.jmedchem.6b00579" @default.
- W2394692324 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27186676" @default.
- W2394692324 hasPublicationYear "2016" @default.
- W2394692324 type Work @default.
- W2394692324 sameAs 2394692324 @default.
- W2394692324 citedByCount "50" @default.
- W2394692324 countsByYear W23946923242016 @default.
- W2394692324 countsByYear W23946923242017 @default.
- W2394692324 countsByYear W23946923242018 @default.
- W2394692324 countsByYear W23946923242019 @default.
- W2394692324 countsByYear W23946923242020 @default.
- W2394692324 countsByYear W23946923242021 @default.
- W2394692324 countsByYear W23946923242022 @default.
- W2394692324 countsByYear W23946923242023 @default.
- W2394692324 crossrefType "journal-article" @default.
- W2394692324 hasAuthorship W2394692324A5002450016 @default.
- W2394692324 hasAuthorship W2394692324A5002661071 @default.
- W2394692324 hasAuthorship W2394692324A5013277489 @default.
- W2394692324 hasAuthorship W2394692324A5019291385 @default.
- W2394692324 hasAuthorship W2394692324A5020019896 @default.
- W2394692324 hasAuthorship W2394692324A5027269469 @default.
- W2394692324 hasAuthorship W2394692324A5031046349 @default.
- W2394692324 hasAuthorship W2394692324A5039360390 @default.
- W2394692324 hasAuthorship W2394692324A5039832836 @default.
- W2394692324 hasAuthorship W2394692324A5056975844 @default.
- W2394692324 hasAuthorship W2394692324A5057830915 @default.
- W2394692324 hasAuthorship W2394692324A5074149482 @default.
- W2394692324 hasAuthorship W2394692324A5077666079 @default.
- W2394692324 hasAuthorship W2394692324A5080610727 @default.
- W2394692324 hasAuthorship W2394692324A5082475531 @default.
- W2394692324 hasAuthorship W2394692324A5085462851 @default.
- W2394692324 hasConcept C104317684 @default.
- W2394692324 hasConcept C119157956 @default.
- W2394692324 hasConcept C150903083 @default.
- W2394692324 hasConcept C185592680 @default.